0000882104-14-000030.txt : 20140415
0000882104-14-000030.hdr.sgml : 20140415
20140415184705
ACCESSION NUMBER: 0000882104-14-000030
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140410
FILED AS OF DATE: 20140415
DATE AS OF CHANGE: 20140415
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Montez David
CENTRAL INDEX KEY: 0001582712
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 14766199
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD.
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
4
1
wf-form4_139760201397312.xml
FORM 4
X0306
4
2014-04-10
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001582712
Montez David
C/O PDL BIOPHARMA
932 SOUTHWOOD BLVD.
INCLINE VILLAGE
NV
89451
0
1
0
0
Controller and CAO
Common stock
2014-04-10
4
A
0
11088
8.22
A
14758
D
The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 12, 2015; 16.66% on December 12, 2016; 16.66% on December 12, 2017; and 16.66% on December 12, 2018.
/s/ Danny J Hart, Jr., Attorney-in-Fact for David Montez
2014-04-15